Terms: = Astrocytoma AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Diagnosis
57 results:
1. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract] [Full Text] [Related]
2. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
3. Glioblastoma patients' survival and its relevant risk factors during the pre-COVID-19 and post-COVID-19 pandemic: real-world cohort study in the USA and China.
Qin L; Li H; Zheng D; Lin S; Ren X
Int J Surg; 2024 May; 110(5):2939-2949. PubMed ID: 38376848
[TBL] [Abstract] [Full Text] [Related]
4. The Glioblastoma CircularRNAome.
Tirpe A; Streianu C; Tirpe SM; Kocijancic A; Pirlog R; Pirlog B; Busuioc C; Pop OL; Berindan-Neagoe I
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833993
[TBL] [Abstract] [Full Text] [Related]
5. Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence.
Fuentes-Fayos AC; G-García ME; Pérez-Gómez JM; Montero-Hidalgo AJ; Martín-Colom J; Doval-Rosa C; Blanco-Acevedo C; Torres E; Toledano-Delgado Á; Sánchez-Sánchez R; Peralbo-Santaella E; Ortega-Salas RM; Jiménez-Vacas JM; Tena-Sempere M; López M; Castaño JP; Gahete MD; Solivera J; Luque RM
EBioMedicine; 2023 Apr; 90():104484. PubMed ID: 36907105
[TBL] [Abstract] [Full Text] [Related]
6. The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma.
Li X; Moreira DC; Bag AK; Qaddoumi I; Acharya S; Chiang J
Neuro Oncol; 2023 Apr; 25(4):750-760. PubMed ID: 36260562
[TBL] [Abstract] [Full Text] [Related]
7. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
Verdugo E; Puerto I; Medina MÁ
Cancer Commun (Lond); 2022 Nov; 42(11):1083-1111. PubMed ID: 36129048
[TBL] [Abstract] [Full Text] [Related]
8. Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer.
Urbaniak A; Reed MR; Heflin B; Gaydos J; Piña-Oviedo S; Jędrzejczyk M; Klejborowska G; Stępczyńska N; Chambers TC; Tackett AJ; Rodriguez A; Huczyński A; Eoff RL; MacNicol AM
Biomed Pharmacother; 2022 Sep; 153():113440. PubMed ID: 36076555
[TBL] [Abstract] [Full Text] [Related]
9. Role of Circular RNA in Brain Tumor Development.
Ahmed SP; Castresana JS; Shahi MH
Cells; 2022 Jul; 11(14):. PubMed ID: 35883576
[TBL] [Abstract] [Full Text] [Related]
10. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
Kabir F; Apu MNH
Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
[TBL] [Abstract] [Full Text] [Related]
11. Utilisation of semiconductor sequencing for the detection of predictive biomarkers in glioblastoma.
Williams G; Llewelyn A; Thatcher R; Hardisty KM; Loddo M
PLoS One; 2022; 17(3):e0245817. PubMed ID: 35324914
[TBL] [Abstract] [Full Text] [Related]
12. Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms.
Salami R; Salami M; Mafi A; Vakili O; Asemi Z
Cell Commun Signal; 2022 Jan; 20(1):13. PubMed ID: 35090496
[TBL] [Abstract] [Full Text] [Related]
13. LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/akt signaling pathway.
Geng S; Tu S; Fu W; Wang J; Bai Z
Cell Cycle; 2021 Oct; 20(19):1988-1998. PubMed ID: 34470587
[TBL] [Abstract] [Full Text] [Related]
14. mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme.
Ramaiah MJ; Kumar KR
Mol Biol Rep; 2021 May; 48(5):4813-4835. PubMed ID: 34132942
[TBL] [Abstract] [Full Text] [Related]
15. Twisted gastrulation signaling modulator 1 promotes the ability of glioma cell through activating akt pathway.
Liu Z; Li H
Neuroreport; 2021 Feb; 32(3):198-205. PubMed ID: 33534374
[TBL] [Abstract] [Full Text] [Related]
16. Involvement of EGFR, ERK-1,2 and akt-1,2 Activity on Human Glioma Cell Growth.
Alahverdi A; Arefian E; Soleimani M; Ai J; Yousefi-Ahmadipour A; Babaei A; Islam MS; Ebrahimi-Barough S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3469-3475. PubMed ID: 33369441
[TBL] [Abstract] [Full Text] [Related]
17. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
Suwala AK; Stichel D; Schrimpf D; Kloor M; Wefers AK; Reinhardt A; Maas SLN; Kratz CP; Schweizer L; Hasselblatt M; Snuderl M; Abedalthagafi MSJ; Abdullaev Z; Monoranu CM; Bergmann M; Pekrun A; Freyschlag C; Aronica E; Kramm CM; Hinz F; Sievers P; Korshunov A; Kool M; Pfister SM; Sturm D; Jones DTW; Wick W; Unterberg A; Hartmann C; Dodgshun A; Tabori U; Wesseling P; Sahm F; von Deimling A; Reuss DE
Acta Neuropathol; 2021 Jan; 141(1):85-100. PubMed ID: 33216206
[TBL] [Abstract] [Full Text] [Related]
18. Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3.
Fuentes-Fayos AC; Vázquez-Borrego MC; Jiménez-Vacas JM; Bejarano L; Pedraza-Arévalo S; L-López F; Blanco-Acevedo C; Sánchez-Sánchez R; Reyes O; Ventura S; Solivera J; Breunig JJ; Blasco MA; Gahete MD; Castaño JP; Luque RM
Brain; 2020 Dec; 143(11):3273-3293. PubMed ID: 33141183
[TBL] [Abstract] [Full Text] [Related]
19. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/akt/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract] [Full Text] [Related]
20. Identification of two core genes in glioblastomas with different isocitrate dehydrogenase mutation status.
Guo Y; Wang X; Ning W; Zhang H; Yu C
Mol Biol Rep; 2020 Oct; 47(10):7477-7488. PubMed ID: 32915403
[TBL] [Abstract] [Full Text] [Related]
[Next]
